Literature DB >> 24082558

Immunohistochemical Expression of Cell Proliferating Nuclear Antigen (PCNA) and p53 Protein in Cervical Cancer.

Goel Madhumati1, Somani Kavita, Mehrotra Anju, Singh Uma, Mehrotra Raj.   

Abstract

OBJECTIVE: This study was designed to evaluate the immunohistochemical expression of proliferating cell nuclear antigen (PCNA) and p53 protein expression in preneoplastic and neoplastic lesions in uterine cervix. STUDY
DESIGN: A total of 36 cervical biopsies were subjected for immunostaining and the results were correlated with different prognostic parameters. Bivariate and multivariate statistical analyses were done using "STATA" software.
RESULTS: PCNA labeling index and p53 expression increased with increasing severity of CIN lesions. PCNA labeling index was maximum (46.0) carcinoma cervix with intense positive staining. In bivariate statistical analysis, p53 and PCNALI were found to be insignificant (0.4184 and 0.4328, respectively). Menopausal stage was significantly associated with CA and CIN groups (P < 0.166 and P < 0.049), respectively.
CONCLUSION: These markers may be of greater importance in low-grade CIN lesions showing high proliferative index. This will place the low-grade lesions in higher grade indicating the utility of proliferative markers in decision making for intervention. This method is simple and cost effective and may be useful in developing countries where HPVDNA testing is still out of reach because of high cost.

Entities:  

Keywords:  Cervix; Immunohistochemistry; PCNA; p53

Year:  2012        PMID: 24082558      PMCID: PMC3526699          DOI: 10.1007/s13224-012-0180-6

Source DB:  PubMed          Journal:  J Obstet Gynaecol India        ISSN: 0975-6434


  16 in total

1.  Effect of organised screening on cervical cancer incidence and mortality in Finland, 1963-1995: recent increase in cervical cancer incidence.

Authors:  A Anttila; E Pukkala; B Söderman; M Kallio; P Nieminen; M Hakama
Journal:  Int J Cancer       Date:  1999-09-24       Impact factor: 7.396

2.  Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study.

Authors:  M H Stoler; M Schiffman
Journal:  JAMA       Date:  2001-03-21       Impact factor: 56.272

3.  p53, Bcl-2, PCNA expression, and apoptotic rates during cervical tumorigenesis.

Authors:  Horacio Astudillo; Tezcatlipoca Lopez; Sebastian Castillo; Patricio Gariglio; Luis Benitez
Journal:  Ann N Y Acad Sci       Date:  2003-12       Impact factor: 5.691

Review 4.  Immunohistochemical markers of cellular proliferation: achievements, problems and prospects.

Authors:  P A Hall; A L Woods
Journal:  Cell Tissue Kinet       Date:  1990-11

5.  Inter- and intra-observer variation in the histopathological reporting of cervical squamous intraepithelial lesions using a modified Bethesda grading system.

Authors:  W G McCluggage; M Y Walsh; C M Thornton; P W Hamilton; A Date; L M Caughley; H Bharucha
Journal:  Br J Obstet Gynaecol       Date:  1998-02

6.  MIB-1 and PCNA immunostaining as a diagnostic adjunct to cervical Pap smear.

Authors:  M M Goel; Anju Mehrotra; Uma Singh; H P Gupta; J S Misra
Journal:  Diagn Cytopathol       Date:  2005-07       Impact factor: 1.582

7.  Telomerase activity, MIB-1, PCNA, HPV 16 and p53 as diagnostic markers for cervical intraepithelial neoplasia.

Authors:  M Herbsleb; U B Knudsen; T F Orntoft; P Bichel; B Norrild; A Knudsen; O Mogensen
Journal:  APMIS       Date:  2001-09       Impact factor: 3.205

8.  Predictive significance of the alterations of p16INK4A, p14ARF, p53, and proliferating cell nuclear antigen expression in the progression of cervical cancer.

Authors:  Jian-Liu Wang; Bi-Ying Zheng; Xi-Dan Li; Tord Angström; Mikael S Lindström; Keng-Ling Wallin
Journal:  Clin Cancer Res       Date:  2004-04-01       Impact factor: 12.531

9.  Immunohistochemical analysis of p53 protein overexpression in normal, premalignant, and malignant tissues of the cervix uteri.

Authors:  R Holm; H Skomedal; A Helland; G Kristensen; A L Børresen; J M Nesland
Journal:  J Pathol       Date:  1993-01       Impact factor: 7.996

10.  Immunohistochemical analysis of p53 oncoprotein and proliferating cell nuclear antigen (PCNA) in the cervix uteri.

Authors:  M R Cardillo; G W Stamp; M N Pignatelli; E N Lalani
Journal:  Eur J Gynaecol Oncol       Date:  1993       Impact factor: 0.196

View more
  10 in total

1.  Long noncoding RNA CCHE1 promotes cervical cancer cell proliferation via upregulating PCNA.

Authors:  Meng Yang; Xu Zhai; Bairong Xia; Yanying Wang; Ge Lou
Journal:  Tumour Biol       Date:  2015-04-29

2.  Quantitative global proteome and lysine succinylome analyses provide insights into metabolic regulation and lymph node metastasis in gastric cancer.

Authors:  Yongxi Song; Jun Wang; Zhongyi Cheng; Peng Gao; Jingxu Sun; Xiaowan Chen; Chen Chen; Yunlong Wang; Zhenning Wang
Journal:  Sci Rep       Date:  2017-02-06       Impact factor: 4.379

3.  Risk Categorization with Different Grades of Cervical Pre-Neoplastic Lesions - High Risk HPV Associations and Expression of p53 and RARβ

Authors:  D Ghosh; A K Roy; N Murmu; S Mandal; A Roy
Journal:  Asian Pac J Cancer Prev       Date:  2019-02-26

4.  Identification of Hub Genes as Potential Prognostic Biomarkers in Cervical Cancer Using Comprehensive Bioinformatics Analysis and Validation Studies.

Authors:  Han Xue; Zhaojun Sun; Weiqing Wu; Dong Du; Shuping Liao
Journal:  Cancer Manag Res       Date:  2021-01-08       Impact factor: 3.989

5.  Elevated serum expression of p53 and association of TP53 codon 72 polymorphisms with risk of cervical cancer in Bangladeshi women.

Authors:  Md Shaki Mostaid; Sadia Biswas Mumu; Md Aminul Haque; Shahana Sharmin; Mohd Raeed Jamiruddin; Ghazi Muhammad Sayedur Rahman; Hasan Mahmud Reza
Journal:  PLoS One       Date:  2021-12-28       Impact factor: 3.240

6.  ROC-Analysis Derived Immunohistochemical P53 Cut-Off Scores as an Adjunct to Routine Histopathology for Better Diagnostic Compartmentalisation of Cervical Lesions.

Authors:  Ayushi Shukla; Rekha Sachan; Malti Maurya; Munna Lal Patel; Pushplata Sankhwar
Journal:  Int J Appl Basic Med Res       Date:  2022-07-26

7.  Network Topologies Decoding Cervical Cancer.

Authors:  Sarika Jalan; Krishna Kanhaiya; Aparna Rai; Obul Reddy Bandapalli; Alok Yadav
Journal:  PLoS One       Date:  2015-08-26       Impact factor: 3.240

Review 8.  Biomarkers of HIV-associated Cancer.

Authors:  Brian Thabile Flepisi; Patrick Bouic; Gerhard Sissolak; Bernd Rosenkranz
Journal:  Biomark Cancer       Date:  2014-07-03

9.  Correlation of P16 (Ink4a) and CK17 to HPV (16E6+18E6) in Premalignant and Malignant Lesions of Uterine Cervix: A Clinicopathologic Study.

Authors:  Mohammed K Chaloob; Alaa G Hussein; Ban J Qasim
Journal:  Iran J Pathol       Date:  2016

10.  SULF2 promotes tumorigenesis and inhibits apoptosis of cervical cancer cells through the ERK/AKT signaling pathway.

Authors:  Tao Jiang; Zhao-Hui Chen; Zhe Chen; Dan Tan
Journal:  Braz J Med Biol Res       Date:  2020-02-07       Impact factor: 2.590

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.